44 related articles for article (PubMed ID: 10550148)
1. Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomas.
FabrÃcio Vde C; Amado F; Del Giglio A
Sao Paulo Med J; 2008 Jan; 126(1):63-6. PubMed ID: 18425290
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC).
Kashyap L; Patil V; Noronha V; Joshi A; Menon N; Jobanputra K; Saha S; Chaturvedi P; Banavali SD; Prabhash K
Ecancermedicalscience; 2021; 15():1325. PubMed ID: 35211194
[TBL] [Abstract][Full Text] [Related]
3. Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her-2-neu, and GADD45 expression in oral squamous cell carcinoma.
Pandey M; Kannepali KK; Dixit R; Kumar M
World J Surg Oncol; 2018 Jan; 16(1):20. PubMed ID: 29386013
[TBL] [Abstract][Full Text] [Related]
4. A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.
Ansari M; Omidvari S; Mosalaei A; Ahmadloo N; Mosleh-Shirazi MA; Mohammadianpanah M
Iran Red Crescent Med J; 2011 Mar; 13(3):187-91. PubMed ID: 22737461
[TBL] [Abstract][Full Text] [Related]
5. Sequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients - Single institute experience.
Somani N; Goyal S; Pasricha R; Khuteta N; Agarwal P; Garg AK; Singhal H
Indian J Med Paediatr Oncol; 2011 Apr; 32(2):86-91. PubMed ID: 22174496
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer.
Ahn JS; Cho SH; Kim OK; Lee JK; Yang DH; Kim YK; Lee JJ; Lim SC; Kim HJ; Chung WK; Chung IJ
Cancer Res Treat; 2007 Sep; 39(3):93-8. PubMed ID: 19746222
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel in the treatment of squamous cell carcinoma of the head and neck.
Rapidis A; Sarlis N; Lefebvre JL; Kies M
Ther Clin Risk Manag; 2008 Oct; 4(5):865-86. PubMed ID: 19209269
[TBL] [Abstract][Full Text] [Related]
8. Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.
Bhide SA; Ahmed M; Barbachano Y; Newbold K; Harrington KJ; Nutting CM
Br J Cancer; 2008 Jul; 99(1):57-62. PubMed ID: 18560402
[TBL] [Abstract][Full Text] [Related]
9. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.
Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H
J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Mochimatu I; Ishitoya J; Kawai S; Mikami Y; Matsuda H; Tanigaki Y; Horiuchi C; Ikeda Y; Taguchi T; Ono M; Yoshida T; Hirose S; Sakuma Y; Yamamoto K
Br J Cancer; 2004 Jan; 90(2):348-52. PubMed ID: 14735175
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck.
Posner MR; Lefebvre JL
Br J Cancer; 2003 Jan; 88(1):11-7. PubMed ID: 12556952
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy with docetaxel, cisplatin, fluorouracil and l-leucovorin for locally advanced head and neck cancers: a modified regimen for Japanese patients.
Watanabe A; Taniguchi M; Sasaki S
Anticancer Drugs; 2003 Nov; 14(10):801-7. PubMed ID: 14597874
[TBL] [Abstract][Full Text] [Related]
13. Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
Kamnerdsupaphon P; Chitapanarux I; Lorvidhaya V; Sumitsawan Y; Tharavichitkul E; Sukthomya V
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1869-73. PubMed ID: 19011334
[TBL] [Abstract][Full Text] [Related]
14. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.
Posner MR; Colevas AD; Tishler RB
Semin Oncol; 2000 Aug; 27(4 Suppl 8):13-24. PubMed ID: 10952434
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel in squamous cell cancer of the head and neck.
Posner MR
Anticancer Drugs; 2001 Feb; 12 Suppl 1():S21-4. PubMed ID: 11340900
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck.
Colevas AD; Norris CM; Tishler RB; Fried MP; Gomolin HI; Amrein P; Nixon A; Lamb C; Costello R; Barton J; Read R; Adak S; Posner MR
J Clin Oncol; 1999 Nov; 17(11):3503-11. PubMed ID: 10550148
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
